Athira Pharma, Inc.
NASDAQ:ATHA
0.3278 (USD) • At close March 11, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Assets: | |||||||
| Current Assets: | |||||||
| Cash & Cash Equivalents
| 48.438 | 90.584 | 95.966 | 110.537 | 60.625 | 2.056 | 3.317 |
| Short Term Investments
| 2.837 | 56.835 | 104.378 | 143.222 | 124.057 | 0 | 1.5 |
| Cash and Short Term Investments
| 51.275 | 147.419 | 200.344 | 253.759 | 184.682 | 2.056 | 4.817 |
| Net Receivables
| 0 | 1.628 | 1.227 | 2.336 | 1.3 | 0.007 | 0.006 |
| Inventory
| 0 | 0 | -1.227 | -2.336 | -1.3 | 0 | 0 |
| Other Current Assets
| 3.566 | 5.682 | 5.962 | 4.704 | 6.355 | 0.097 | 0.074 |
| Total Current Assets
| 54.841 | 154.729 | 207.533 | 260.799 | 192.337 | 2.16 | 4.897 |
| Non-Current Assets: | |||||||
| Property, Plant & Equipment, Net
| 3.252 | 4.437 | 5.316 | 5.217 | 3.585 | 0 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 44.829 | 65.936 | 83.509 | 0.029 | 0.036 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.686 | 1.079 | 0.475 | 0.056 | 0.132 | 0 | 0 |
| Total Non-Current Assets
| 3.938 | 5.516 | 50.62 | 71.209 | 87.226 | 0.029 | 0.036 |
| Total Assets
| 58.779 | 160.245 | 258.153 | 332.008 | 279.563 | 2.189 | 4.933 |
| Liabilities & Equity: | |||||||
| Current Liabilities: | |||||||
| Account Payables
| 0.319 | 0.129 | 2.501 | 0.567 | 1.158 | 0.421 | 0.121 |
| Short Term Debt
| 0.414 | 0.368 | 0.652 | 0.576 | 0.248 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 12.402 | 28.343 | 18.278 | 8.149 | 2.999 | 0.852 | 0.451 |
| Total Current Liabilities
| 13.135 | 28.84 | 21.431 | 9.292 | 4.405 | 1.273 | 0.572 |
| Non-Current Liabilities: | |||||||
| Long Term Debt
| 0.803 | 1.217 | 1.585 | 1.632 | 0.876 | 1.553 | 0.722 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | 0 | 19.086 | 18.526 |
| Total Non-Current Liabilities
| 0.803 | 1.217 | 1.585 | 1.632 | 0.876 | 20.639 | 19.248 |
| Total Liabilities
| 13.938 | 30.057 | 23.016 | 10.924 | 5.281 | 21.912 | 19.82 |
| Equity: | |||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 279.563 | 17.051 | 17.051 |
| Common Stock
| 0.004 | 0.004 | 0.004 | 0.004 | 0.003 | 0.003 | 0.003 |
| Retained Earnings
| -406.146 | -309.206 | -191.534 | -95.895 | -41.042 | -21.087 | -15.926 |
| Accumulated Other Comprehensive Income/Loss
| 0.001 | -0.349 | -1.956 | -0.388 | 0.033 | -17.054 | -17.054 |
| Other Total Stockholders Equity
| 450.982 | 439.739 | 428.623 | 417.363 | 315.288 | 1.367 | 1.039 |
| Total Shareholders Equity
| 44.841 | 130.188 | 235.137 | 321.084 | 274.282 | -19.723 | -14.887 |
| Total Equity
| 44.841 | 130.188 | 235.137 | 321.084 | 274.282 | -19.723 | -14.887 |
| Total Liabilities & Shareholders Equity
| 58.779 | 160.245 | 258.153 | 332.008 | 279.563 | 2.189 | 4.933 |